CymaBay Therapeutics Inc. (CBAY) Receives Consensus Rating of "Buy" from Brokerages

... Marshall Wace North America L.P. purchased a new stake in CymaBay Therapeutics in the 2nd quarter worth $242,000. Ardsley Advisory Partners increased its stake in CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now owns ...
http://ift.tt/2lnHntZ